- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Correction: L-Arginine in diabetes: clinical and preclinical evidence ; volume:22 ; number:1 ; day:18 ; month:5 ; year:2023 ; pages:1 ; date:12.2023
Cardiovascular diabetology ; 22, Heft 1 (18.5.2023), 1, 12.2023
- Urheber
-
Forzano, Imma
Avvisato, Roberta
Varzideh, Fahimeh
Jankauskas, Stanislovas S.
Cioppa, Angelo
Mone, Pasquale
Salemme, Luigi
Kansakar, Urna
Tesorio, Tullio
Trimarco, Valentina
Santulli, Gaetano
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-023-01852-1
- URN
-
urn:nbn:de:101:1-2023090911521935271173
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Forzano, Imma
- Avvisato, Roberta
- Varzideh, Fahimeh
- Jankauskas, Stanislovas S.
- Cioppa, Angelo
- Mone, Pasquale
- Salemme, Luigi
- Kansakar, Urna
- Tesorio, Tullio
- Trimarco, Valentina
- Santulli, Gaetano
- SpringerLink (Online service)
Ähnliche Objekte (12)
L-Arginine in diabetes: clinical and preclinical evidence
Correction: A novel strategy for L-arginine production in engineered Escherichia coli
Transport of L-Arginine Related Cardiovascular Risk Markers
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Controlled drug delivery of L-Arginine from a polymer matrix
L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis
Decreased diabetes risk over 9 year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)
A novel strategy for l-arginine production in engineered Escherichia coli
Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production
L-Arginine in diabetes: clinical and preclinical evidence
Correction: A novel strategy for L-arginine production in engineered Escherichia coli
Transport of L-Arginine Related Cardiovascular Risk Markers
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Controlled drug delivery of L-Arginine from a polymer matrix
L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis
Decreased diabetes risk over 9 year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)
A novel strategy for l-arginine production in engineered Escherichia coli
Lactobacillus plantarum ameliorates NASH-related inflammation by upregulating l-arginine production
L-Arginine in diabetes: clinical and preclinical evidence
Correction: A novel strategy for L-arginine production in engineered Escherichia coli
Transport of L-Arginine Related Cardiovascular Risk Markers
L-Arginine supplementation as mitochondrial therapy in diabetic cardiomyopathy
Controlled drug delivery of L-Arginine from a polymer matrix
Cleansing effect of acidic L-arginine on human oral biofilm
Purification and characterization of L-arginine deiminase from Penicillium chrysogenum
Controlled drug delivery of L-Arginine from a polymer matrix
L-arginine Supplementation Ameliorates Chronic Bone Loss in Rheumatoid Arthritis
Decreased diabetes risk over 9 year after 18-month oral l-arginine treatment in middle-aged subjects with impaired glucose tolerance and metabolic syndrome (extension evaluation of l-arginine study)
A novel strategy for l-arginine production in engineered Escherichia coli